Revelation Biosciences, Inc.
USD1.03
-0.01 (-0.96%)
CEO
James Rolke
IPO Date
2020-11-17
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$1.04
Prev. Close
$1.04
Day Low
$1.03
Day High
$1.07
52W Low
$0.88
52W High
$12.88
Market Cap
$0.00B
Volume
0.01M
| -1.0 |
| 31 Dec 2023 | FY | 0.0% | 0.0% | -1.8% | -1.0% | 0.00 | 2.18 | -342.7 |
| 31 Dec 2022 | FY | 0.0% | 0.0% | -1029.0% | -196.8% | 0.00 | 1.22 | -4.0 |
| 31 Dec 2021 | FY | 0.0% | 0.0% | 12050.7% | -587.0% | -0.17 | 0.89 | -33.6 |
| 31 Dec 2020 | FY | 0.0% | 0.0% | -47.8% | -35.3% | 0.00 | 1.35 | -74.8 |
| 31 Dec 2019 | FY | 0.0% | 0.0% | 100.0% | -16.0% | 0.00 | 0.00 | -97628.9 |
| -0.2 |
| 30 Sept 2025 | Q3 | 0.0% | 0.0% | -17.3% | -14.8% | 0.00 | 6.92 | -2.0 |
| 30 Jun 2025 | Q2 | 0.0% | 0.0% | -63.9% | -45.3% | 0.00 | 3.42 | -0.7 |
| 31 Mar 2025 | Q1 | 0.0% | 0.0% | -71.2% | -51.7% | 0.00 | 3.61 | -3.7 |
| 31 Dec 2024 | Q4 | 50.0% | -6400.1% | -36.7% | -26.1% | 0.00 | 3.43 | -4.4 |
| 30 Sept 2024 | Q3 | 0.0% | 0.0% | -83.8% | -33.3% | 0.00 | 1.64 | -3.1 |
| 30 Jun 2024 | Q2 | 0.0% | 0.0% | -735.7% | -68.4% | 0.00 | 1.10 | -1.1 |
| 31 Mar 2024 | Q1 | 0.0% | 0.0% | -28.3% | -18.2% | 0.00 | 2.80 | -3.2 |
| 31 Dec 2023 | Q4 | 50.0% | -5862.8% | -33.1% | -18.0% | 0.00 | 2.18 | -5.4 |